This morning we sent you our “early bid” momentumalert on GNTA, a triple zero stock with a piece of info tucked away in an SEC filing that we just couldn’t ignore!
We let you know that inside this SEC filing from Monday night there was a statement regarding GNTA’s lead drug Tesetaxel. The company had received approval to start clinical trials in China, but had not yet made this announcement public!
That scenario just SOUNDED like money waiting to be made!
GNTA closed at just .0007 yesterday and our report went out at 9:20AM EST this morning. The stock saw prices in the .0008 – .0009 range in the early minutes of trading, but we are now sitting in the .0012 – .0014 range! Not a bad way to start off the day huh?
Did you miss this morning’s email where we uncovered a HUGE hidden piece of info inside of one of GNTA’s SEC filings?
If you missed GNTA then stay tuned for what we have in store for tonight!
Upon receipt of this email, you acknowledge that you have read our Disclaimer: